\documentclass{article}
\usepackage[a4paper,margin=0.4in,tmargin=0.5in,landscape]{geometry}
\usepackage{tabu}
\pagenumbering{gobble}
\begin{document}
\begin{center}
\footnotesize
\begin{tabu}{| c | c | c | c | c | c | c |}
\hline
\rowfont{\bfseries} ID & name & $K_a$ (M$^{-1}$) & $\Delta G$ (kcal/mol) $^{(a)}$ & $\Delta H$ (kcal/mol) & $T\Delta S$ (kcal/mol) $^{(b)}$ & $n$ \\
\hline
\hline
clip-g1 & 4-azaniumylbutylammonium & 31000.0 +- 9000.0 & -6.1 +- 0.2 & -6.1 +- 0.8 & 0.0 +- 0.8 &  0.86 \\
\hline
clip-g2 & 5-azaniumylpentylammonium & 1270000.0 +- 80000.0 & -8.32 +- 0.04 & -8.8 +- 0.3 & -0.4 +- 0.3 &  1.00 \\
\hline
clip-g3 & 6-azaniumylhexylammonium & 24000000.0 +- 3000000.0 & -10.05 +- 0.07 & -10.9 +- 0.3 & -0.8 +- 0.3 &  0.90 \\
\hline
clip-g15 & trimethyl-[6-(trimethylammonio)hexyl]ammonium & 52000000.0 +- 4000000.0 & -10.52 +- 0.05 & -12.8 +- 0.4 & -2.2 +- 0.4 &  0.97 \\
\hline
clip-g12 & hexyl(trimethyl)ammonium & 1210000.0 +- 70000.0 & -8.29 +- 0.03 & -8.4 +- 0.3 & -0.1 +- 0.3 &  0.94 \\
\hline
clip-g5 & 8-azaniumyloctylammonium & 150000000.0 +- 30000000.0 & -11.1 +- 0.1 & -11.4 +- 0.4 & -0.3 +- 0.4 &  0.89 \\
\hline
clip-g16 & 10-azaniumyldecylammonium & 300000000.0 +- 100000000.0 & -11.5 +- 0.2 & -11.2 +- 0.4 & 0.3 +- 0.4 &  0.89 \\
\hline
clip-g17 & 12-azaniumyldodecylammonium & 500000000.0 +- 300000000.0 & -11.8 +- 0.4 & -10.4 +- 0.3 & 1.4 +- 0.5 &  0.97 \\
\hline
clip-g9 & 1-adamantylammonium & 360000.0 +- 30000.0 & -7.57 +- 0.05 & -4.8 +- 0.2 & 2.8 +- 0.2 &  0.95 \\
\hline
clip-g6 & 1-adamantyl(trimethyl)ammonium & 11000000.0 +- 2000000.0 & -9.6 +- 0.1 & -10.2 +- 0.4 & -0.6 +- 0.4 &  0.83 \\
\hline
clip-g11 & 1-(1-adamantyl)ethanamine & 4100000.0 +- 600000.0 & -9.02 +- 0.08 & -7.4 +- 0.3 & 1.6 +- 0.3 &  0.85 \\
\hline
clip-g10 & Can't format in LaTeX & 1000000.0 +- 100000.0 & -8.17 +- 0.08 & -5.8 +- 0.2 & 2.3 +- 0.2 &  0.99 \\
\hline
clip-g8 & [4-(azaniumylmethyl)phenyl]methylammonium & 8500000.0 +- 700000.0 & -9.45 +- 0.05 & -10.6 +- 0.3 & -1.1 +- 0.3 &  0.90 \\
\hline
clip-g18 & 1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium & 54000000.0 +- 8000000.0 & -10.55 +- 0.09 & -12.4 +- 0.4 & -1.8 +- 0.4 &  0.95 \\
\hline
clip-g19 & 4-(1,1-dimethylpiperidin-1-ium-4-yl)-1,1-dimethyl-piperidin-1-ium & 360000000.0 +- 80000000.0 & -11.7 +- 0.1 & -13.6 +- 0.4 & -2.0 +- 0.5 &  0.79 \\
\hline
clip-g7 & (4-azaniumylcyclohexyl)ammonium & 59000.0 +- 5000.0 & -6.5 +- 0.05 & -6.7 +- 0.3 & -0.2 +- 0.3 &  0.83 \\
\hline
\hline
OA-g1 & hexanoate & 4400.0 +- 200.0 & -4.97 +- 0.02 & -5.54 +- 0.1 & -0.57 +- 0.07 &  1.00 \\
\hline
OA-g2 & 4-chlorobenzoate & 116000.0 +- 5000.0 & -6.91 +- 0.02 & -9.6 +- 0.3 & -2.6 +- 0.2 &  1.00 \\
\hline
OA-g3 & (4~{S})-4-isopropenylcyclohexene-1-carboxylate & 870000.0 +- 40000.0 & -8.1 +- 0.02 & -12.0 +- 0.02 & -3.9 +- 0.02 &  1.00 \\
\hline
OA-g4 & (3~{S})-3,7-dimethyloct-6-enoate & 91000.0 +- 7000.0 & -6.76 +- 0.05 & -6.7 +- 0.2 & 0.1 +- 0.1 &  1.00 \\
\hline
OA-g5 & Can't format in LaTeX & 3000.0 +- 100.0 & -4.73 +- 0.02 & -7.48 +- 0.05 & -2.75 +- 0.05 &  1.00 \\
\hline
OA-g6 & hexyl(trimethyl)ammonium & 4400.0 +- 200.0 & -4.97 +- 0.02 & -7.3 +- 0.3 & -2.3 +- 0.3 &  1.00 \\
\hline
OA-g7 & trimethyl-(4-methylcyclohexyl)ammonium & 28000.0 +- 2000.0 & -6.07 +- 0.05 & -5.7 +- 0.2 & 0.3 +- 0.1 &  1.00 \\
\hline
OA-g8 & 1-adamantyl(trimethyl)ammonium & 1110000.0 +- 40000.0 & -8.25 +- 0.02 & -7.8 +- 0.2 & 0.4 +- 0.1 &  1.00 \\
\hline
\hline
exoOA-g1 & hexanoate & NaN +- NaN & NaN +- NaN & NaN +- NaN & NaN +- NaN &  1.00 \\
\hline
exoOA-g2 & 4-chlorobenzoate & 9.0 +- 4.0 & -1.3 +- 0.3 & NaN +- NaN & NaN +- NaN &  1.00 \\
\hline
exoOA-g3 & (4~{S})-4-isopropenylcyclohexene-1-carboxylate & 300.0 +- 40.0 & -3.37 +- 0.07 & -6.0 +- 0.1 & -2.65 +- 0.07 &  1.00 \\
\hline
exoOA-g4 & (3~{S})-3,7-dimethyloct-6-enoate & 440.0 +- 20.0 & -3.61 +- 0.02 & -7.3 +- 0.7 & -3.7 +- 0.7 &  1.00 \\
\hline
exoOA-g5 & Can't format in LaTeX & 12100.0 +- 500.0 & -5.57 +- 0.02 & -6.17 +- 0.02 & -0.6 +- 0.02 &  1.00 \\
\hline
exoOA-g6 & hexyl(trimethyl)ammonium & 18900.0 +- 800.0 & -5.83 +- 0.02 & -3.25 +- 0.02 & 2.58 +- 0.02 &  1.00 \\
\hline
exoOA-g7 & trimethyl-(4-methylcyclohexyl)ammonium & 130000.0 +- 20000.0 & -6.98 +- 0.1 & -4.97 +- 0.07 & 2.01 +- 0.05 &  1.00 \\
\hline
exoOA-g8 & 1-adamantyl(trimethyl)ammonium & 420000.0 +- 20000.0 & -7.67 +- 0.02 & -5.04 +- 0.05 & 2.63 +- 0.02 &  1.00 \\
\hline
\hline
bCD-g1 & trans-4-methylcyclohexanol & 2100.0 +- 100.0 & -4.52 +- 0.03 & -2.6 +- 0.2 & 2.0 +- 0.2 &  0.88 \\
\hline
bCD-g2 & R-rimantadine & 35000.0 +- 3000.0 & -6.2 +- 0.04 & -10.4 +- 0.7 & -4.2 +- 0.7 &  1.00 \\
\hline
\hline
MGLab\_8-g1 & trans-4-methylcyclohexanol & 260.0 +- 20.0 & -3.3 +- 0.05 & -1.8 +- 0.4 & 1.5 +- 0.4 &  0.89 \\
\hline
MGLab\_8-g2 & R-rimantadine & 830.0 +- 50.0 & -3.98 +- 0.04 & -6.9 +- 0.5 & -2.9 +- 0.5 &  1.03 \\
\hline
\hline
MGLab\_9-g1 & trans-4-methylcyclohexanol & 210.0 +- 20.0 & -3.17 +- 0.05 & -2.7 +- 0.8 & 0.4 +- 0.8 &  0.88 \\
\hline
MGLab\_9-g2 & R-rimantadine & 700.0 +- 40.0 & -3.88 +- 0.03 & -9.0 +- 0.6 & -5.2 +- 0.6 &  1.00 \\
\hline
\hline
MGLab\_19-g1 & trans-4-methylcyclohexanol & 210.0 +- 20.0 & -3.18 +- 0.04 & -2.1 +- 0.2 & 1.1 +- 0.2 &  0.83 \\
\hline
MGLab\_19-g2 & R-rimantadine & 320.0 +- 20.0 & -3.41 +- 0.04 & -11.0 +- 1.0 & -8.0 +- 1.0 &  0.94 \\
\hline
\hline
MGLab\_23-g1 & trans-4-methylcyclohexanol & 220.0 +- 20.0 & -3.2 +- 0.05 & -3.0 +- 1.0 & 0.0 +- 1.0 &  0.76 \\
\hline
MGLab\_23-g2 & R-rimantadine & 1510.0 +- 90.0 & -4.33 +- 0.04 & -7.6 +- 0.5 & -3.3 +- 0.5 &  0.96 \\
\hline
\hline
MGLab\_24-g1 & trans-4-methylcyclohexanol & 280.0 +- 20.0 & -3.34 +- 0.05 & -1.6 +- 0.2 & 1.7 +- 0.2 &  0.92 \\
\hline
MGLab\_24-g2 & R-rimantadine & 1100.0 +- 70.0 & -4.15 +- 0.04 & -8.6 +- 0.6 & -4.5 +- 0.6 &  1.03 \\
\hline
\hline
MGLab\_34-g1 & trans-4-methylcyclohexanol & 700.0 +- 100.0 & -3.85 +- 0.09 & -3.7 +- 0.3 & 0.1 +- 0.3 &  0.81 \\
\hline
MGLab\_34-g2 & R-rimantadine & 11000.0 +- 7000.0 & -5.5 +- 0.4 & -9.0 +- 2.0 & -3.0 +- 2.0 &  0.99 \\
\hline
\hline
MGLab\_35-g1 & trans-4-methylcyclohexanol & 2300.0 +- 200.0 & -4.58 +- 0.05 & -4.5 +- 0.3 & 0.1 +- 0.3 &  0.85 \\
\hline
MGLab\_35-g2 & R-rimantadine & 27000.0 +- 2000.0 & -6.04 +- 0.04 & -7.3 +- 0.5 & -1.2 +- 0.5 &  0.78 \\
\hline
\hline
MGLab\_36-g1 & trans-4-methylcyclohexanol & 200.0 +- 10.0 & -3.15 +- 0.04 & -3.0 +- 0.3 & 0.1 +- 0.3 &  0.87 \\
\hline
MGLab\_36-g2 & R-rimantadine & 350.0 +- 20.0 & -3.48 +- 0.04 & -11.0 +- 1.0 & -7.0 +- 1.0 &  0.84 \\
\hline
\end{tabu}\end{center}\vspace{5mm}
All quantities are reported as point estimate +- statistical error from the ITC data fitting procedure. The upper bound ($1\%$) was used for errors reported to be $<1\%$. We also included a 3\% relative uncertainty in the titrant concentration assuming the stoichiometry coefficient to be fitted to the ITC data [1] for the Isaacs (TrimerTrip) and Gilson (cyclodextrin derivatives) datasets, where concentrationerror had not been factored in to the original error estimates. For the OA/exoOA sets, provided uncertaintiesalready included concentration error.\\
($^a$) Statistical errors were propagated from the $K_a$ measurements. \\
($^b$) All experiments were performed at 298 K. \\
($^c$) Units of M$^{-2}$. \\
($^d$) Units of M$^{-3}$.
\end{document}
